Skip to main content
. 2021 Jul 7;4(7):e2114723. doi: 10.1001/jamanetworkopen.2021.14723

Table 3. Factors Associated With Overall Survival at 5 Years.

Factor Training set Testing set
HR (95% CI) P value HR (95% CI) P value
Sex
Women 1 [Reference] NA 1 [Reference] NA
Men 1.23 (1.16-1.30) <.001 1.303 (1.17-1.44) <.001
Age 1.02 (1.01-1.02) <.001 1.02 (1.01-1.02) <.001
Smoking status
Nonsmoker 1 [Reference] NA 1 [Reference] NA
Smoker 1.66 (1.46-1.89) <.001 1.92 (1.51-2.44) <.001
Stage
1 1 [Reference] NA 1 [Reference] NA
2 1.73 (1.54-1.94) <.001 1.32 (1.08-1.61) <.001
3 2.92 (2.66-3.20) <.001 2.44 (2.08-2.86) <.001
4 5.08 (4.65-5.54) <.001 4.83 (4.16-5.62) <.001
Histologic type
Adenocarcinoma 1 [Reference] NA 1 [Reference] NA
Squamous cell carcinoma 1.05 (0.98-1.13) .16 1.14 (1.01-1.29) .03
Other 1.52 (1.40-1.65) <.001 1.32 (1.16-1.51)) <.001
BMI
Reference range 1 [Reference] NA 1 [Reference] NA
Obesity 0.88 (0.80-0.97) .01 0.86 (0.73-1.01) .06
Overweight 0.90 (0.83-0.98) .02 0.90 (0.78-1.04) .15
Underweight 1.28 (1.06-1.55) .01 0.94 (0.65-1.35) .73
Missing 1.38 (1.28-1.49) <.001 1.32 (1.16-1.51) <.001
Albumin, g/dL
≤3.5 1 [Reference] NA 1 [Reference] NA
>3.5 0.66 (0.61-0.71) <.001 0.59 (0.52-0.68) <.001
Missing 0.48 (0.41-0.57) <.001 0.45 (0.34-0.61) <.001
Alkaline phosphatase, U/L
≤140 1 [Reference] NA 1 [Reference] NA
>140 1.40 (1.27-1.54) <.001 1.54 (1.29-1.83) <.001
Missing 1.17 (0.99-1.38) .06 1.09 (0.81-1.47) .57
Creatinine, mg/dL
Reference rangea 1 [Reference] NA 1 [Reference] NA
High 1.02 (0.95-1.10) .57 0.93 (0.81-1.06) .27
Low 1.45 (1.26-1.67) <.001 1.45 (1.26-1.67) <.001
Missing 1.19 (0.90-1.57) .22 0.93 (0.81-1.06) .16
Hemoglobin, g/dL
Reference rangeb 1 [Reference] NA 1 [Reference] NA
High 1.35 (1.08-1.70) .01 1.34 (0.89-2.03) .15
Low 1.16 (1.09-1.24) <.001 1.06 (0.95-1.19) .28
Missing 1.56 (0.96-2.55) .07 0.54 (0.18-1.65) .32
Red cell distribution width, %
≤14.5 1 [Reference] NA 1 [Reference] NA
>14.5 1.12 (1.05-1.20) <.001 1.36 (1.20-1.53) <.001
Missing 0.74 (0.46-1.20) .23 0.84 (0.27-2.61) .77
WBC count, per μL
4500-11 000 1 [Reference] NA 1 [Reference] NA
≥11 000 1.17 (1.09-1.25) <.001 1.24 (1.10-1.40) <.001
Missing 1.01 (0.64-1.59) .97 2.82 (0.73-10.91) .13
Neutrophil-lymphocyte ratio
≤4 1 [Reference] NA 1 [Reference] NA
>4 1.34 (1.25-1.43) <.001 1.23 (1.10-1.38) <.001
Missing 0.85 (0.76-0.96) .01 0.98 (0.80-1.20) .83
Calcium, mg/dL
8.5-10.5 1 [Reference] NA 1 [Reference] NA
≥8.5 0.72 (0.66-0.79) <.001 0.68 (0.58-0.79) <.001
≥10.5 1.37 (1.17-1.59) <.001 1.56 (1.15-2.11) .003
Missing 1.08 (0.84-1.40) .54 1.12 (0.75-1.67) .59
Sodium, mEq/L
135-145 1 [Reference] NA 1 [Reference] NA
<135 1.32 (1.23-1.43) <.001 1.25 (1.10-1.43) <.001
>145 0.95 (0.77-1.16) .59 1.07 (0.74-1.55) .72
Missing 1.04 (0.73-1.48) .82 0.97 (0.58-1.65) .92

Abbreviations: BMI, body mass index; HR, hazard ratio; NA, not applicable; WBC, white blood cell.

SI conversion factors: To convert albumin to grams per liter, multiply by 10; alkaline phosphatase to microkatals per liter, multiply by 0.0167; calcium to millimoles per liter, multiply by 0.25; creatinine to micromoles per liter, multiply by 88.4; hemoglobin to grams per liter, multiply by 10.0; sodium to millimoles per liter, multiply by 1.0; WBC count to × 109 per liter, multiply by 0.001.

a

The reference range for creatinine is 0.6 to 1.2 mg/dL for men and 0.5 to 1.1 mg/dL for women.

b

The reference range for hemoglobin is 13.5 to 17.5 g/dL for men and 12.0 to 15.5 g/dL for women.